Pediatric Tonsillectomy Indications

Tonsillectomy was one of the most commonly performed operations in children throughout the 20th century, often performed liberally for recurrent sore throats, enlarged tonsils, and general ill health. The Paradise trial (1984) was the first rigorous RCT to evaluate tonsillectomy for recurrent throat infection. In severely affected children (≥7 episodes/year for 1 year, ≥5/year for 2 years, or ≥3/year for 3 years), surgery reduced the frequency of throat infections over 2 years compared to watchful waiting. However, the benefit was modest — the control group also improved substantially over time — and the trial highlighted that many children improve regardless of surgery. This study established the 'Paradise criteria' that remain the benchmark for surgical indication based on recurrent infection, while also raising questions about whether the benefit justifies the surgical risk in an era of declining rheumatic fever.

The Childhood Adenotonsillectomy Trial (CHAT), published in the New England Journal of Medicine in 2013, was the landmark RCT that established the modern evidence base for tonsillectomy in the most common current indication: pediatric obstructive sleep apnea (OSA). CHAT randomized 464 children aged 5-9 with polysomnography-confirmed OSA to early adenotonsillectomy versus watchful waiting with supportive care. Surgery produced significant improvements in polysomnographic parameters (PSG normalization: 79% surgery vs 46% watchful waiting), behavior, quality of life, and daytime sleepiness at 7 months. However, 46% of the watchful waiting group also normalized, and there was no difference in attention or executive function (the primary outcome). CHAT established that while adenotonsillectomy clearly improves OSA in children, a substantial proportion of mild-moderate cases resolve spontaneously, supporting shared decision-making rather than universal surgery.

The POST trial (Pediatric OSA Tonsillectomy, Netherlands) and several other European studies extended the CHAT findings, examining whether tonsillectomy benefits children with milder OSA or those not meeting strict polysomnographic criteria. Tonsillotomy (partial intracapsular tonsillectomy) emerged as a less morbid alternative to total tonsillectomy for OSA, with multiple RCTs demonstrating less postoperative pain, faster recovery, and lower bleeding risk, with comparable short-to-medium term efficacy for airway obstruction. A Cochrane review confirmed tonsillotomy's reduced morbidity profile. However, tonsil regrowth after tonsillotomy occurs in approximately 5-15% of cases, with some requiring revision surgery. For recurrent infection, the UK ATOS trial found that tonsillectomy provided modest benefit over conservative management in less severely affected children (not meeting Paradise criteria), with the NNT of approximately 7 to prevent one episode of significant sore throat per year.

The AAO-HNS Clinical Practice Guideline for Tonsillectomy in Children (2019 update) recommends tonsillectomy for recurrent throat infections meeting the Paradise criteria and for obstructive sleep-disordered breathing. The guideline endorses watchful waiting as an alternative to surgery for recurrent infection in children who do not meet Paradise criteria and for mild OSA. It recommends polysomnography before tonsillectomy for children <2 years and those with obesity, Down syndrome, craniofacial anomalies, or neuromuscular disorders. The guideline notes that tonsillotomy (partial tonsillectomy) is an option for OSA but not for recurrent infection. NICE guidelines recommend tonsillectomy only for recurrent sore throat meeting specific frequency criteria, emphasizing conservative management first.

The primary indication for pediatric tonsillectomy has shifted from recurrent infection to obstructive sleep-disordered breathing, which now accounts for the majority of cases. Evidence-based indications are better defined than ever, but tonsillectomy remains one of the most variable procedures in pediatric surgery, with substantial geographic and provider-level variation. Tonsillotomy is gaining adoption for OSA indications, particularly in Europe, offering reduced morbidity with comparable short-term efficacy but requiring long-term vigilance for tonsil regrowth. Emerging research focuses on identifying children with OSA most likely to benefit from surgery (phenotyping), the long-term immune consequences of tonsillectomy, and the role of drug-induced sleep endoscopy (DISE) in children to guide surgical planning. The development of non-surgical treatments for pediatric OSA (nasal steroids, montelukast, orthodontic expansion) provides alternatives for mild cases.